Maralixibat Chloride
CAS 2281132-56-0 5 FDA-DMF suppliersSmall Molecule
Overview
Maralixibat Chloride is a selective inhibitor of the ileal bile acid transporter (IBAT/ASBT) indicated for the treatment of cholestatic pruritus in patients with Alagille syndrome. This therapeutic agent works by reducing the reabsorption of bile acids in the intestine, thereby lowering bile acid levels in patients.
Therapeutic areas
Pediatric Cholestasis
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.